星珠药业进行生产经营业务调整，将主要业务集中在中药前处理提取业务上，在生产范围为中药饮片的 《药品生产许可证》有效期届满后，不再申请重新发证，将该《药品生产许可证》注销。星珠药业2024 年中药饮片业务没有产生营业收入。 格隆汇12月15日丨白云山(00874.HK)发布公告，近日，广东省药品监督管理局发布了《广东省药品监督 管理局关于注销<药品生产许可证>的通告(2025年第102号)》，公司子公司广州白云山星珠药业有限公 司(以下简称"星珠药业")《药品生产许可证》已注销，本次注销的原因是星珠药业进行生产经营业务调 整，在生产范围为中药饮片的《药品生产许可证》有效期届满后不再申请重新发证。 ...

星珠药业进行生产经营业务调整，将主要业务集中在中药前处理提取业务上，在生产范围为中药饮片的 《药品生产许可证》有效期届满后，不再申请重新发证，将该《药品生产许可证》注销。星珠药业2024 年中药饮片业务没有产生营业收入。 白云山(00874)发布公告，近日，广东省药品监督管理局发布了《广东省药品监督管理局关于注销 <药品 生产许可证> 的通告(2025年第102号)》，广州白云山医药集团股份有限公司(以下简称"本公司")子公司 广州白云山星珠药业有限公司(以下简称"星珠药业")《药品生产许可证》已注销，本次注销的原因是星 珠药业进行生产经营业务调整，在生产范围为中药饮片的《药品生产许可证》有效期届满后不再申请重 新发证。 ...

廣州白雲山醫藥集團股份有限公司 董事會 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出的。 茲刊載廣州白雲山醫藥集團股份有限公司（「本公司」）在上海證券交易所網站(www.sse.com.cn)刊登的 本公司關於子公司《藥品生產許可證》註銷的公告之中文全文，僅供參考。 中國廣州，2025年12月15日 於本公告日，本公司董事會成員包括執行董事李小軍先生、陳傑輝先生、程寧女士、程洪進先生、 唐和平先生與黎洪先生，及獨立非執行董事陳亞進先生、黃民先生、黃龍德先生與孫寶清女士。 证券代码：600332 证券简称：白云山 公告编号：2025-086 广州白云山医药集团股份有限公司 关于子公司《药品生产许可证》注销的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 近日，广东省药品监督管理局 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 近日，广东省药品监督管理局发布了《广东省药品监督管理局 关于注销<药品生产许可证>的通告（2025 年第 102 号）》，广州白 云山医药集团股份有限公司（以下简称"本公司"）子公司广州白 云山星珠药业有限公司（以下简称"星珠药业"）《药品生产许可 证》已注销，本次注销的原因是星珠药业进行生产经营业务调整， 在生产范围为中药饮片的《药品生产许可证》有效期届满后不再申 请重新发证。现将相关情况公告如下： 一、《药品生产许可证》基本情况 企业名称：广州白云山星珠药业有限公司 证券代码：600332 证券简称：白云山 公告编号：2025-086 广州白云山医药集团股份有限公司 关于子公司《药品生产许可证》注销的公告 分类码：Ay 注册地址：广州市从化明珠工业园创业大道南 4 号 发证机关：广东省药品监督管理局 有效期至：2025 年 9 月 9 日 许可证编号：粤 20160117 生产地址和生产范围：广州市从化明珠工业园创业大道南 4 号， 中药饮片（净制、切制、炒制、蒸制、炙制） ...

Core Insights - The Guangdong-Hong Kong-Macao Greater Bay Area is positioned as a key area for promoting new industrialization and intelligent manufacturing, driven by its strong industrial foundation and rich application scenarios [1][2] Group 1: Industry Development - The 2025 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence and Robotics Industry Conference (XAIR Conference) was held in Guangzhou from December 12 to 14, focusing on the applications and integration of AI and robotics in manufacturing and transportation [1] - In the first ten months of this year, the core AI industry scale in Guangdong exceeded 230 billion yuan, with over 40% of industrial robots and over 80% of service robots produced in the province, maintaining the highest industrial robot output in the country for five consecutive years [1] Group 2: Corporate Initiatives - Guangdong Unicom has established the China Unicom (Guangdong) New Industrialization Research Institute, forming a team of over 1,000 experts to support digital transformation and innovation in the industrial sector [2][4] - The company is focusing on three key areas in the "AI + Manufacturing" sector: building a robust "cloud-network-computing-intelligence-security" foundation, enhancing platform applications, and accelerating AI empowerment in new industrialization [4] Group 3: Alliance Formation - The "Guangdong Province Artificial Intelligence + Manufacturing Industry Alliance" was officially established, aiming to tackle technical challenges, promote efficient sharing of production factors, and enhance the transition of technology from labs to large-scale production [5] - The alliance, initiated by Guangdong Unicom and leading manufacturing enterprises, has formed a team of over 1,000 professionals and established over 20,000 5G industry-specific networks, managing over 12.5 million devices and creating 800 5G factories [5]

Core Insights - The Guangdong-Hong Kong-Macao Greater Bay Area is positioned as a key area for promoting new industrialization and intelligent manufacturing upgrades, leveraging its strong industrial foundation and rich application scenarios [1][3] Group 1: Event Overview - The 2025 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence and Robotics Industry Conference and the Guangdong Province Artificial Intelligence and Robotics Skills Competition (XAIR Conference) took place in Guangzhou from December 12 to 14 [1] - The "AIR + Manufacturing" forum focused on critical questions regarding the transition of robots from stage use to factory applications and the construction of intelligent workshops and factories [1] Group 2: Digital Transformation Initiatives - Guangdong has implemented various policies to support the digital transformation of its manufacturing sector, including the establishment of a leadership group for AI and robotics innovation [3] - Over 400 digital transformation benchmark demonstrations have been created, with 51,000 industrial enterprises undergoing digital transformation, enhancing revenue and efficiency [3] Group 3: AI and Manufacturing Integration - Chen Xin, an academician, emphasized that AI + manufacturing represents not just a technological overlap but a complete reconfiguration of the manufacturing industry, necessitating collaboration across various sectors [5] - Guangdong Unicom is focusing on three key areas in the AI + manufacturing sector: establishing a robust cloud-network-computing foundation, developing platforms for device management and intelligent decision-making, and deepening real-world applications in eight major industrial clusters [5][7] Group 4: Industry Collaboration and Ecosystem Development - The establishment of the "Guangdong Province AI + Manufacturing Industry Alliance" aims to integrate resources and expertise from various stakeholders to foster an innovative ecosystem for AI and manufacturing [7] - Major companies like Midea and Baiyun Electric are actively applying AI technologies to enhance their manufacturing processes, with Midea focusing on intelligent supply chain algorithms and Baiyun Electric developing comprehensive intelligent control solutions [7]

上市企业：云南白药（000538）,同仁堂（600085）,片仔癀（600436）,白云山（600332）,太极集团 （600129）,东阿阿胶（000423）,九芝堂（000989）,贵州百灵（002424）,葵花药业（002737）,吉林敖 东（000623） 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 根据国家统计局数据显示：2025年10月中国中成药产量为15万吨，同比下降9.6%；2025年1-10月中国中 成药累计产量为147.2万吨，累计下降8.8%。 2020-2025年1-10月中国中成药产量统计图 相关报告：智研咨询发布的《2026-2032年中国中成药行业发展形势分析及产业前景规划报告》 ...

据天眼查APP显示，广州白云山医药集团股份有限公司成立于1997年09月01日，注册资本162579.0949 万人民币。（数据宝） 12月12日白云山大宗交易一览 | 成交量 | 成交金 额 | 成交价 | 相对当日 收盘折溢 | | | | --- | --- | --- | --- | --- | --- | | （万 | | 格 | | 买方营业部 | 卖方营业部 | | 股） | （万 | （元） | 价 | | | | | 元） | | （%） | | | | 24.21 | 630.09 | 26.03 | 0.00 | 瑞银证券有限责任公司上海花园石桥路证券营业 部 | 机构专用 | | 11.73 | 305.33 | 26.03 | 0.00 | 中信证券股份有限公司总部(非营业场所) | 机构专用 | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （原标题：白云山现2笔大宗交易 合计成交35.94万股） 白云山12月12日大宗交易平台共发生2笔成交，合计成交量35.94万股，成交金额935.42万元。成交价格 均为26.03元。从参与大宗交易营业部来看，机构专用席位共出现 ...

Core Viewpoint - The establishment of the "Guangdong Artificial Intelligence + Manufacturing Industry Alliance" aims to drive the transformation and upgrading of the manufacturing sector in Guangdong through the integration of artificial intelligence and robotics, addressing key challenges and fostering a new development ecosystem [1][4]. Group 1: Industry Transformation - The manufacturing industry in China is undergoing a critical transformation, with artificial intelligence as a key driver for this change, necessitating collaboration among education, technology, and industry sectors [1][3]. - Guangdong is focusing on deep integration of artificial intelligence and robotics into manufacturing, with over 400 digital transformation benchmarks established and more than 50,000 industrial enterprises undergoing transformation [2][4]. Group 2: Challenges and Solutions - Current challenges in the manufacturing sector include the labor-intensive nature of production and the limitations of traditional industrial robots, which struggle to meet the demands of flexible production [2][3]. - There is a pressing need for "embodied intelligent robots" that combine artificial intelligence with structural intelligence to address specific operational challenges in the manufacturing of thin electronic products [2][3]. Group 3: Alliance Goals and Structure - The newly formed alliance has set five vision goals, including tackling core technology challenges, promoting resource collaboration, and accelerating the practical application of artificial intelligence technologies [4][5]. - The alliance aims to create a comprehensive ecosystem that includes standard setting, testing, certification, and iterative optimization, allowing members to share technological benefits and market opportunities [5][6]. Group 4: Talent Development - A comprehensive talent system is being established to support the intelligent transformation of manufacturing, focusing on training AI engineers and key personnel in smart manufacturing [6][7]. - Guangdong Unicom is actively building a talent pool of over 1,000 experts to support industrial digital transformation and has already implemented 38 intelligent demonstration scenarios in collaboration with major enterprises [6][7].

信达证券研报指出，白云山25Q3报表端已企稳修复，冲击圆满完成"十四五"，重点布局"十五五"。2025 年公司基本已完成治理层及中层干部调整，新治理层、新经营理念、新发展起点，且2025Q3报表端已 呈现出业绩拐点。在白云山新的治理层的领导下，公司的经营质量有望逐步提升。目前公司聚焦国际 化、数字化、研发创新、治理改善等。在研发创新方面，白云山制药总厂研发的BYS10片进入关键注册 临床试验，有望成为国产创新抗肿瘤药物的代表性产品。2025年10月，广药集团召开"十五五"战略规划 项目阶段性成果汇报会。在新一轮战略布局下，公司有望迎来发展新态势，以战略规划为引领，以数字 化转型为引擎，赋能公司高质量发展。公司2025H1大健康板块收入增速仍超7%，收入规模达70亿元。 公司目前正推行多个新品以及国际化战略。首次覆盖，给予公司"买入"投资评级。 ...